Neurosurgery Prior Authorization and Denial Guide
Prior authorization requirements, denial patterns, implant documentation protocols, and appeal frameworks for spinal surgery, spinal cord stimulators, and neurosurgical hardware billing. Grounded in Aetna CPB #0016, UHC CDG Spine Surgery, CMS LCDs for spinal cord stimulators, and NASS evidence-based clinical guidelines for spine care.
Cervical and lumbar fusion: commercial payers require prior authorization for spinal fusion, and most route spine surgery PA through eviCore or AIM Specialty Health. Documentation requirements include 6 weeks of failed conservative care (physical therapy, activity modification, NSAIDs), imaging (MRI or CT) confirming the structural pathology corresponding to the clinical syndrome, neurological examination documenting the deficit or radiculopathy correlating with the imaging, and for multi-level fusion, documentation of the medical necessity for each additional level beyond the primary level. Adjacent-level fusion following prior fusion requires documentation of new pathology at the adjacent level and failure of conservative management.
Spinal cord stimulator implantation: Aetna CPB #0016 and UHC CDG for SCS require documented failure of at least 6 months of conservative care, psychological evaluation, and a successful trial period (typically 3–7 days with ≥50% pain reduction on validated scales). The permanent implant requires prior authorization separate from the trial authorization. Implant hardware documentation must identify the manufacturer, model, and implant code for all hardware implanted. Lumbar laminectomy without fusion (CPT 63030, 63047) requires documentation of the spinal level, neural element compression confirmed on imaging, and functional limitation — most commercial payers require conservative care failure documentation even for clearly compressive pathology causing radiculopathy.